| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.00 bn | 2.00 bn | 2.00 bn | 2.00 bn | 2.00 bn | 2.00 bn |
| Cash burn (monthly) | (no burn) | 390.32 mm | 91.46 mm | 99.84 mm | 69.08 mm | 64.61 mm |
| Cash used (since last report) | n/a | 790.83 mm | 185.31 mm | 202.30 mm | 139.97 mm | 130.91 mm |
| Cash remaining | n/a | 1.21 bn | 1.82 bn | 1.80 bn | 1.86 bn | 1.87 bn |
| Runway (months of cash) | n/a | 3.1 | 19.9 | 18.0 | 26.9 | 29.0 |
| 13F holders | Current |
|---|---|
| Total holders | 312 |
| Opened positions | 60 |
| Closed positions | 43 |
| Increased positions | 92 |
| Reduced positions | 102 |
| 13F shares | Current |
|---|---|
| Total value | 6.55 tn |
| Total shares | 658.90 mm |
| Total puts | 738.50 k |
| Total calls | 573.10 k |
| Total put/call ratio | 1.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Dexcel Pharma Technologies | 98.17 mm | $0.00 |
| QVT Financial | 65.79 mm | $778.34 bn |
| SB Investment Advisers | 62.06 mm | $734.14 bn |
| FMR | 49.30 mm | $583.24 bn |
| Viking Global Investors | 47.81 mm | $565.59 bn |
| Vanguard | 44.09 mm | $521.55 bn |
| BlackRock | 42.16 mm | $498.72 bn |
| MS Morgan Stanley | 34.62 mm | $409.50 bn |
| STT State Street | 20.80 mm | $246.08 bn |
| Rubric Capital Management | 20.00 mm | $236.60 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Feb 25 | Matthew Gline | Common Shares | Payment of exercise | Dispose F | No | No | 10.72 | 10,945 | 117.33 k | 17,316,601 |
| 20 Feb 25 | Rakhi Kumar | Common Shares | Payment of exercise | Dispose F | No | No | 10.72 | 958 | 10.27 k | 162,306 |
| 20 Feb 25 | Eric Venker | Common Shares | Payment of exercise | Dispose F | No | No | 10.72 | 10,945 | 117.33 k | 885,924 |
| 20 Feb 25 | Eric Venker | Common Shares | Sell | Dispose S | No | No | 10.65 | 100,000 | 1.07 mm | 896,869 |
| 20 Feb 25 | Eric Venker | Common Shares | Option exercise | Acquire M | No | No | 3.85 | 100,000 | 385.00 k | 996,869 |
| 20 Feb 25 | Eric Venker | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.85 | 100,000 | 385.00 k | 10,926,234 |
| 13 Feb 25 | Rakhi Kumar | Common Shares | Sell | Dispose S | No | No | 10.43 | 227,500 | 2.37 mm | 163,264 |
| 13 Feb 25 | Rakhi Kumar | Common Shares | Option exercise | Acquire M | No | No | 3.85 | 187,500 | 721.88 k | 390,764 |
| 13 Feb 25 | Rakhi Kumar | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.85 | 187,500 | 721.88 k | 312,500 |
